![Peter McNamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter McNamara
No más puestos en curso
Fortuna: 2 M $ al 30/06/2026
Perfil
Dr. Peter McNamara is a Chief Scientific Officer at Tectonic Therapeutic, Inc. Dr. McNamara was previously employed as a Chief Scientific Officer by AVROBIO, Inc., an Executive Director-Biotherapeutics & Biotechnology by Novartis Institute for Functional Genomics, Inc., and a Director-Pharmacology by Phenomix Corp.
He received his undergraduate degree from National University of Ireland Galway and a doctorate degree from National University of Ireland Galway.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,29 % | 30/06/2026 | 55.285 ( 0,29 % ) | 2 M $ | 30/06/2026 |
Cargos activos de Peter McNamara
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Peter McNamara.
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | 01/04/2021 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 01/08/2005 |
| TECTONIC THERAPEUTIC, INC. | Director Técnico/Científico/I+D | - |
Formación de Peter McNamara.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
16
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Peter McNamara
